We demonstrated that persistent KOR activation by chronic treatment with U50488, a selective KOR agonist, increased depression like symptoms in C57BL/6J mice, which were blocked by KOR antagonist norBNI and tricyclic antidepressant imipramine, but not by SSRIs fluoxetine and citalopram. This evidence concerns the gene OPRK1 and depressive disorder.